Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02937675 |
Title | A Phase 1-2 Dose-Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Hematological Malignancies |
Recruitment | Terminated |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Effector Therapeutics |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Samuel Oschin comprehensive Cancer Institute at Cedars-Sinai Medical Center | Los Angeles | California | 90048 | United States | Details | |
Florida Cancer Specialist | Sarasota | Florida | 34232 | United States | Details | |
Karmanos Cancer Institute | Detroit | Michigan | 48201 | United States | Details | |
Henry Ford Hospital | Detroit | Michigan | 48202 | United States | Details | |
Mayo Clinic | Rochester | Minnesota | 55905 | United States | Details | |
University of Rochester | Rochester | New York | 14642 | United States | Details | |
Gabrail Cancer Center Research | Canton | Ohio | 44718 | United States | Details | |
Baylor Scott & White Research Institute | Dallas | Texas | 75246 | United States | Details | |
Seattle Cancer Care Alliance | Seattle | Washington | 98109 | United States | Details | |
West Virginia University | Morgantown | West Virginia | 26506 | United States | Details |